This is a non-core endpoint: only basic statistics are computed.
Carcinoma in situ of uteri, other/unspecified
CD2_INSITU_CERVIX_UTERI_NOS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
228 |
4. Check minimum number of eventsNone |
228 |
5. Include endpointsNone |
228 |
6. Filter based on genotype QC (FinnGen only) |
225 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of uteri, other/unspecified
based on the number of shared cases.
Similar with more cases:
- HSIL lesion of the cervix uteri
- HSIL lesion of the cervix uteri, vagina or vulva
- All dysplastic lesions of the cervix uteri
- All dysplastic lesions of the cervix uteri, vagina or vulva
- Neoplasms
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 225 | 225 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 35.70 | 35.70 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 228
- Matched controls
- 2280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/2-C53.9
ICD-O-3
Squamous cell carcinoma in situ, NOS, of cervix uteri
694.1
171.2
149
6
D06.9
ICD-10 Finland
Carcinoma in situ: Cervix, unspecified
+∞
148.7
126
*
2331A
ICD-9 Finland
Carcinoma in situ of breast and genito-urinary system, Cervix uteri
+∞
117.0
102
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
15.8
70.8
70
62
8326
FHL
Batch conization
301.0
67.1
65
*
ULA02
NOMESCO Finland
Kolposcopy
9.0
58.0
98
176
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
8.3
53.1
96
184
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
17.3
49.9
44
31
LDA10
NOMESCO Finland
Curettage of cervix uteri
9.4
37.7
51
68
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
113.4
36.0
38
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.4
32.2
87
233
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
6.1
27.7
57
118
D06.1
ICD-10 Finland
Carcinoma in situ: Exocervix
115.1
19.9
21
*
LDC00
NOMESCO Finland
Conisation of cervix uteri using knife
+∞
15.8
15
*
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
171.3
15.7
16
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
16.7
12.9
20
13
8076/3-C53.9
ICD-O-3
Squamous cell carcinoma, microinvasive of cervix uteri
+∞
8.4
8
*
D06.7
ICD-10 Finland
Carcinoma in situ: Other parts of cervix
+∞
8.4
8
*
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
82.7
7.5
8
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
71.8
6.5
7
*
ZXC00
NOMESCO Finland
Use of diathermy
14.9
6.5
10
7
8140/2-C53.1
ICD-O-3
Adenocarcinoma in situ, NOS, of exocervix
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
105
2.32
3.22
2.3
1.3
—
—
—
0
0
75
533
1.61
2.74
2.0
1.4
—
—
—
0
0
12
231
0.49
1.61
4.2
4.1
28.71
33.70
%
—
7
157
178
1908
0.69
1.41
5.3
5.1
1.72
2.42
mu/l
0.59
170
1781
35
488
0.67
1.40
1.3
1.3
2.07
2.05
u/ml
0.01
11
139
33
228
1.52
1.34
1.6
1.5
1.29
1.29
%
0.02
28
199
56
709
0.72
1.31
1.9
1.8
91.67
100.51
pmol/l
0.92
30
342
21
131
1.66
1.29
1.5
1.5
—
—
—
0
0
186
1971
0.69
1.26
11.2
11.4
18.63
19.29
mg/l
0.11
146
1500
0
33
0.00
1.17
0.0
5.9
—
20.80
—
0
27
0
36
0.00
1.15
0.0
1.2
—
—
—
0
0
0
36
0.00
1.15
0.0
1.2
—
—
—
0
0
7
30
2.37
1.13
1.3
2.2
—
—
—
0
0
213
2186
0.61
0.93
17.7
17.5
39.71
39.87
%
0.16
206
2072
182
1915
0.75
0.90
4.2
4.2
5.90
5.74
mmol/l
0.69
170
1792
34
437
0.74
0.86
1.6
1.5
—
—
—
0
0
75
640
1.26
0.84
3.1
3.1
195.55
20.15
ng/l
0.78
34
378
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
202
2087
0.72
0.77
13.7
13.2
67.10
67.74
umol/l
0.23
202
2087
11
67
1.67
0.76
4.5
3.1
48.05
46.04
%
0.09
11
67
22
160
1.42
0.73
9.4
5.1
233.36
245.92
u/l
0.28
22
150
192
1992
0.77
0.68
12.1
12.4
3.91
3.92
mmol/l
0.30
187
1939
140
1496
0.83
0.64
3.8
4.0
11.60
10.61
mm/h
0.43
134
1380
129
1388
0.84
0.63
2.9
3.2
—
—
—
0
0
192
1989
0.78
0.63
12.1
12.3
139.84
139.90
mmol/l
0.14
187
1938
9
140
0.63
0.62
2.3
3.2
48.78
71.95
ng/l
—
9
125
173
1811
0.81
0.62
5.3
5.0
38.97
38.64
mmol/mol
0.22
162
1702
18
131
1.41
0.61
1.3
1.5
—
—
—
0
0
113
1033
1.19
0.61
3.1
3.9
6.64
6.40
mmol/l
0.51
107
959
13
185
0.68
0.61
1.1
1.3
168.73
153.19
iu/ml
—
7
85
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
72.20
—
0
5
20
150
1.37
0.58
5.3
3.3
4.56
4.59
pmol/l
0.08
20
133
5
86
0.57
0.57
1.0
2.6
36.80
41.29
u/l
—
5
78
103
1120
0.85
0.54
10.4
9.3
3.95
3.86
e9/l
0.15
92
974
33
270
1.26
0.54
3.3
2.4
1.13
1.07
e6/l
0.05
23
140
48
410
1.22
0.53
1.2
1.3
28.59
31.82
iu/ml
0.09
21
146
9
134
0.66
0.53
1.8
1.3
—
—
—
0
0
14
191
0.72
0.53
4.4
4.2
1.04
1.06
mmol/l
0.13
14
172
12
84
1.45
0.50
4.1
8.4
91.93
94.88
%
1.06
12
84
12
165
0.71
0.48
2.4
2.4
—
16.69
—
0
7
12
165
0.71
0.48
2.4
3.0
—
—
—
0
0
34
403
0.82
0.47
1.4
1.4
22.34
22.56
nmol/l
0.03
29
331
49
558
0.84
0.45
1.5
1.7
1.49
1.41
mmol/l
0.30
41
475
106
983
1.15
0.44
6.8
4.8
0.00
0.00
estimate
-0.00
16
189
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
42.55
—
0
11
12
88
1.38
0.41
1.1
1.6
—
—
—
0
0
7
101
0.68
0.40
1.9
1.4
—
—
—
0
0
52
584
0.86
0.40
2.8
2.2
49.57
58.99
u/l
1.37
46
541
106
991
1.13
0.38
4.6
3.5
0.00
0.03
estimate
0.80
15
185
159
1652
0.88
0.37
4.4
4.4
14.75
14.52
pmol/l
0.59
150
1533
96
893
1.13
0.37
2.3
2.4
—
—
—
0
0
5
76
0.65
0.36
7.6
2.1
—
—
—
0
0
29
248
1.19
0.34
3.8
2.6
5.58
4.01
e6/l
0.44
19
118
56
506
1.14
0.33
4.1
3.4
3.88
8.06
mg/mmol
0.79
34
285
206
2097
0.82
0.33
9.6
9.8
26.65
24.28
u/l
0.29
200
2037
184
1888
0.87
0.32
10.8
10.5
84.28
84.40
ml/min/173m2
0.03
153
1536
13
102
1.29
0.30
1.2
1.4
—
—
—
0
0
41
456
0.88
0.28
3.5
1.7
1.34
0.91
mg/l
0.43
34
360
25
289
0.85
0.28
1.5
1.6
1343.05
1178.21
nmol/l
0.40
20
214
48
437
1.12
0.26
2.0
2.1
—
—
—
0
0
26
226
1.17
0.26
1.9
1.6
—
—
—
0
0
9
77
1.18
0.24
4.2
2.1
1.33
1.11
%
—
9
77
6
81
0.73
0.24
3.8
5.7
24.52
25.50
mmol/l
—
6
81
6
84
0.71
0.24
1.0
1.4
—
—
—
0
0
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
2.43
—
0
11
0
10
0.00
0.21
0.0
1.0
—
9.12
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
99.67
—
0
12
74
783
0.92
0.21
5.2
3.5
—
—
—
0
0
20
229
0.86
0.21
2.6
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
60.30
—
0
13
0
13
0.00
0.21
0.0
3.7
—
15.64
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
10.08
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
4.3
—
—
—
0
0
12
144
0.82
0.20
1.2
1.3
—
33.92
—
0
6
0
14
0.00
0.20
0.0
1.0
—
1.25
—
0
6
6
53
1.14
0.19
1.5
1.5
—
—
—
0
0
20
176
1.15
0.18
4.6
6.0
104.45
104.15
mmol/l
0.15
20
176
93
893
1.07
0.17
4.5
5.9
1.22
1.23
mmol/l
0.37
81
763
19
169
1.14
0.15
1.3
1.8
—
—
—
0
0
19
169
1.14
0.15
1.2
1.7
—
—
—
0
0
53
558
0.93
0.13
2.0
2.0
171.79
138.23
u/l
0.23
53
532
19
210
0.90
0.12
2.3
1.8
—
—
—
0
0
19
172
1.11
0.12
2.3
2.4
66.38
71.51
ml/min/173m2
—
8
68
5
64
0.78
0.08
1.8
1.6
212.20
260.64
mu/l
—
5
55
6
71
0.84
0.08
1.8
1.1
—
—
—
0
0
6
71
0.84
0.08
1.8
1.1
—
—
—
0
0
8
77
1.04
0.07
1.7
1.9
—
—
—
0
0
24
255
0.93
0.07
1.3
1.8
—
—
—
0
0
100
980
1.04
0.07
4.7
3.5
0.00
0.00
estimate
-0.00
20
199
9
85
1.06
0.07
1.7
1.5
—
—
—
0
0
196
1975
0.95
0.07
4.0
4.3
4.99
4.96
mmol/l
0.11
186
1869
190
1884
1.05
0.07
3.5
3.8
1.28
1.24
mmol/l
0.35
175
1765
55
534
1.04
0.06
3.6
3.7
0.00
0.00
estimate
-0.00
16
190
43
418
1.04
0.04
1.3
1.3
34.76
10.82
u/ml
0.50
14
176
15
159
0.94
0.03
1.4
2.2
0.24
0.23
g/l
0.41
15
154
199
2000
0.96
0.03
4.5
4.7
2.96
2.95
mmol/l
0.04
187
1877
75
759
0.98
0.02
13.7
8.5
1.26
1.10
inr
0.75
27
240
62
612
1.02
0.01
3.3
2.7
—
—
—
0
0
24
233
1.03
0.01
5.0
5.6
—
—
—
0
0
46
467
0.98
0.01
3.3
2.7
0.16
0.46
e6/l
1.60
37
344
23
236
0.97
0.00
2.7
1.8
28.96
29.66
s
0.25
23
225
16
163
0.98
0.00
3.6
7.0
5.41
5.22
kpa
0.61
16
158
16
163
0.98
0.00
3.6
7.0
11.08
12.39
kpa
0.53
16
158
196
1963
0.99
0.00
3.8
4.2
1.56
1.60
mmol/l
0.86
185
1846
0
6
0.00
-0.00
0.0
1.0
—
12.50
—
0
6
0
9
0.00
-0.00
0.0
2.1
—
63.51
—
0
9
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
53
0.94
-0.00
1.8
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
70
1.00
-0.00
2.6
2.7
8.00
1878.50
u/ml
—
7
63
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
5.86
—
0
5
5
56
0.89
-0.00
1.6
1.1
—
—
—
0
0
5
53
0.94
-0.00
1.8
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
30.83
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
5
53
0.94
-0.00
1.8
1.5
—
—
—
0
0
5
58
0.86
-0.00
1.8
1.6
—
—
—
0
0
5
53
0.94
-0.00
1.8
1.5
—
—
—
0
0
32
320
1.00
-0.00
2.5
3.4
48.74
317.47
ng/l
0.69
19
216
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
76.80
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
55
0.91
-0.00
1.6
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
2.42
—
0
6
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2217.00
—
0
5
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
95.00
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
15.17
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.6
—
192.00
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_CERVIX_UTERI_NOS – Carcinoma in situ of uteri, other/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).